Nika Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
Nika Pharmaceuticals Total Assets Growth & History (NIKA)
Nika Pharmaceuticals's total assets was $20,996 for fiscal 2025.
View full Nika Pharmaceuticals company overviewNika Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $20,996 | $3,062 | +17.07% |
| 2024 | 2024-12-31 | $17,934 | −$1,662 | −8.48% |
| 2023 | 2023-12-31 | $19,596 | $18,732 | +2168.06% |
| 2022 | 2022-12-31 | $864 | $465 | +116.54% |
| 2021 | 2021-12-31 | $399 | −$1,212 | −75.23% |
| 2020 | 2020-12-31 | $1,611 | — | — |
Nika Pharmaceuticals quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9,942 | −$21,665 | −68.54% |
| Q1 2026 | 2026-03-31 | $20,637 | −$14,351 | −41.02% |
| Q4 2025 | 2025-12-31 | $20,996 | $3,062 | +17.07% |
| Q3 2025 | 2025-09-30 | $23,625 | $22,239 | +1604.55% |
| Q2 2025 | 2025-06-30 | $31,607 | −$358,716 | −91.90% |
| Q1 2025 | 2025-03-31 | $34,988 | −$6,485 | −15.64% |
| Q4 2024 | 2024-12-31 | $17,934 | −$1,662 | −8.48% |
| Q3 2024 | 2024-09-30 | $1,386 | −$9,524 | −87.30% |
| Q2 2024 | 2024-06-30 | $390,323 | — | — |
| Q1 2024 | 2024-03-31 | $41,473 | $37,014 | +830.10% |
| Q4 2023 | 2023-12-31 | $19,596 | $18,732 | +2168.06% |
| Q3 2023 | 2023-09-30 | $10,910 | $6,996 | +178.74% |
| Q1 2023 | 2023-03-31 | $4,459 | $4,376 | +5272.29% |
| Q4 2022 | 2022-12-31 | $864 | $465 | +116.54% |
| Q3 2022 | 2022-09-30 | $3,914 | $2,215 | +130.37% |
| Q2 2022 | 2022-06-30 | $8,545 | $8,147 | +2046.98% |
| Q1 2022 | 2022-03-31 | $83 | −$1,274 | −93.88% |
| Q4 2021 | 2021-12-31 | $399 | −$1,212 | −75.23% |
| Q3 2021 | 2021-09-30 | $1,699 | — | — |
| Q2 2021 | 2021-06-30 | $398 | — | — |
| Q1 2021 | 2021-03-31 | $1,357 | — | — |
| Q4 2020 | 2020-12-31 | $1,611 | — | — |
Nika Pharmaceuticals total assets trends
Over the last five fiscal years, Nika Pharmaceuticals's total assets increased from $1,611 to $20,996, a change of $19,385. The latest reported quarter, Q2 2026, shows $9,942.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nika Pharmaceuticals source filings ↗